PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Genedata

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Genedata Expands Biomarker Discovery Collaboration with Syngenta for Metabolomic Data Processing - Genedata, a leading provider of in-silico solutions for pharmaceutical R&D and related life sciences, today announced the extension of a biomarker discovery collaboration with Syngenta, a leading global agrochemical company
Genedata Expands Biomarker Discovery Collaboration with Syngenta for Metabolomic Data Processing

 

NewswireToday - /newswire/ - Watham, MA, United States, 2009/02/25 - Genedata, a leading provider of in-silico solutions for pharmaceutical R&D and related life sciences, today announced the extension of a biomarker discovery collaboration with Syngenta, a leading global agrochemical company.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Syngenta has added the Genedata Expressionist Refiner MS module for LC-MS and GC-MS metabolomic raw data processing and analysis to their existing Genedata Expressionist system. Refiner MS expands Expressionist to process and analyze metabolomic raw MS data separately and in conjunction with microarray data, dramatically improving efficiency and enhancing the biomarker discovery process at Syngenta.

Syngenta has been successfully using the Genedata Expressionist Refiner Array and Analyst modules to process and analyze microarray data since 2005. With the rapid expansion of metabolomics research and the associated data volumes generated, Syngenta now uses Refiner MS to integrate MS data in their biomarker discovery projects.

With Refiner MS Syngenta can process more rapidly and with full confidence in quality extremely large amounts of MS data directly from multiple hardware platforms via user defined, flexible workflows. Peaks selection is performed automatically in Refiner MS while statistical analysis and biological pathway mapping are done in the powerful analytical module Analyst.

“Syngenta’s decision to use the Genedata Expressionist system for our metabolomics research is based on the ability of Refiner MS to capture very large data sets directly from a wide range of instruments quickly and efficiently and to visualize and manipulate data from a wide variety of mass spectrometry experiment types such as GC-MS and data dependent LC-MS/MS experiments all in one computer platform,” said Dr. David Portwood, Head of Metabolomics at Syngenta UK. “A further major benefit is that we can now integrate all the "omics" data types in one platform and can perform multivariate stats within the Analyst module avoiding time consuming exporting and importing of data between software packages and leading, we believe, to greater understanding and insights to the biological processes that are key to the future success of our business.”

“We are very pleased at the continuing development of our relationship with Syngenta, a long-term Genedata customer and a global leader in agrochemical research,” said Dr. Othmar Pfannes, CEO of Genedata. “The expanded use of Expressionist at Syngenta is an excellent showcase of how Genedata’s products are meeting specific needs today for faster and more effective scientific exploration in a variety of life science research processes.”

About Syngenta
Syngenta (syngenta.com) is one of the world's leading companies with more than 24,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life.

About Genedata
Genedata (genedata.com) develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata’s solutions enable scientists to process, integrate, analyze, and manage large and complex experimental data sets generated by high throughput technologies. Solutions include Genedata Phylosopher® for target discovery and integrative biological data management, Genedata Screener® for automated high throughput screening and high content screening, and Genedata Expressionist® for biomarker discovery and personalized medicine. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Boston & San Francisco, USA, Konstanz & Munich, Germany and Tokyo, Japan.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Genedata

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Genedata Expands Biomarker Discovery Collaboration with Syngenta for Metabolomic Data Processing

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Allison Kurz - Genedata.com 
+41 61 511 8459 communications[.]genedata.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Genedata securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Genedata / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022
FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Persistence Market Research (P) Ltd

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)